American Shared Hospital Services Announces Delivery of MEVION S250 Proton Accelerator to UF Health Cancer Center at Orlando ...
05 November 2014 - 12:00AM
Business Wire
AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS),
a leading provider of turnkey technology solutions for advanced
radiosurgical and radiation therapy services, announced today the
delivery of the superconducting synchrocyclotron proton
accelerator—the key element of the MEVION S250™ proton therapy
system—to the dedicated proton center now under development at the
UF Health Cancer Center at Orlando Health.
AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D.,
said, "The delivery of the synchrocyclotron for the MEVION S250 is
a major step forward in the development of the proton center at the
UF Health Cancer Center at Orlando Health. As Central Florida’s
most advanced cancer center, the UF Health Cancer Center at Orlando
Health is the first hospital in the Central Florida region to
install a proton therapy system. Construction of the proton center
is moving forward, and we expect patient treatments to begin in the
first quarter of 2016."
About AMS
American Shared Hospital Services provides turnkey technology
solutions for advanced radiosurgical and radiation therapy
services. AMS is the world leader in providing Gamma Knife
radiosurgery equipment, a non-invasive treatment for malignant and
benign brain tumors, vascular malformations and trigeminal
neuralgia (facial pain). The Company also offers the latest IGRT
and IMRT systems, as well as its proprietary Operating Room for the
21st CenturySM concept. AMS owns a common stock investment in
Mevion Medical Systems, Inc., developer of the compact MEVION S250
Proton Therapy System.
Safe Harbor Statement
This press release may be deemed to contain certain
forward-looking statements with respect to the financial condition,
results of operations and future plans of American Shared Hospital
Services, which involve risks and uncertainties including, but not
limited to, the risks of the Gamma Knife and radiation therapy
businesses, the risks of developing The Operating Room for the 21st
Century program, the risks of investing in a development-stage
company, Mevion Medical Systems, Inc., and the risks of the timing,
financing, and operations of the Company’s proton therapy business.
Further information on potential factors that could affect the
financial condition, results of operations and future plans of
American Shared Hospital Services is included in the filings of the
Company with the Securities and Exchange Commission, including the
Company's Annual Report on Form 10-K and Form 10-K/A for the year
ended December 31, 2013, the Form 10-Q for the quarter ended March
31, 2014 and the Form 10-Q and Form 10-Q/A for the quarter ended
June 30, 2014, and the definitive Proxy Statement for the Annual
Meeting of Shareholders held on June 10, 2014.
American Shared Hospital ServicesErnest A. Bates, M.D.,
(415) 788-5300Chairman and Chief Executive Officereabates@ashs.comorBerkman AssociatesNeil
Berkman, (310) 477-3118Presidentinfo@berkmanassociates.com
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Sep 2023 to Sep 2024